Vaccine adjuvant discovery program

Awarded Award Notice Posted

Solicitation number
BAA-DAIT-75N93022R00022
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to University Of California, San Diego
Set-aside
No set-aside

Opportunity facts

Contract number
75N93024C00022 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Place of performance
La Jolla, California 92037, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases, a civilian agency of the Department of Health and Human Services, has awarded a cost-reimbursement contract valued at $10,517,896 to the University of California, San Diego for the Vaccine Adjuvant Discovery Program. The awarded contract, numbered 75N93024C00022, is not a fixed-price contract and will involve research and development activities related to vaccine adjuvants, which are substances that enhance the immune response to vaccines.

Notice text

This is not fixed-priced. This is a cost-reimbursement contract.

Awarded contract 75N93024C00022 to UNIVERSITY OF CALIFORNIA, SAN DIEGO for 10517896.00 on 2024-09-19.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Vaccine adjuvant discovery program Latest Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program This notice Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program Latest solicitation Solicitation
Vaccine adjuvant discovery program Original Pre-Solicitation

And 1 more award notice.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity